Oral phenylephrine: placebo, in tablet form
On Sept. 12, 2023, an FDA advisory committee concluded that over-the-counter (OTC) oral phenylephrine — the main active ingredient in Sudafed PE — is ineffective as a treatment for nasal congestion. This finding did not strike healthcare practitioners as “especially surprising” given that its efficacy has been controversial for decades. Despite this, the ingredient is […]
Oral phenylephrine: placebo, in tablet form Read More »